Anti-Adenosine A1 Receptor antibody
- BOND RX™ Validated
- What is this?
3
(2 Reviews)
|
(37 Publications)
Rabbit Polyclonal Adenosine A1 Receptor antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Rat, Mouse samples. Cited in 37 publications.
View Alternative Names
Adenosine receptor A1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Adenosine A1 Receptor antibody (AB82477)
IHC image of ab82477 staining in Rat Adult Brain formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab82477, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Adenosine A1 Receptor antibody (AB82477)
ICC/IF image of ab82477 stained PC12 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab82477, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 4% PFA fixed (10 min) PC12 cells at 5µg/ml.
- WB
Unknown
Western blot - Anti-Adenosine A1 Receptor antibody (AB82477)
All lanes:
Western blot - Anti-Adenosine A1 Receptor antibody (ab82477) at 1 µg/mL
Lane 1:
Rat Spinal Ganglion Neuronal cell lysate at 10 µg
Lane 2:
Western blot - EL4 whole cell lysate (<a href='/en-us/products/cell-lysates/el4-whole-cell-lysate-ab7183'>ab7183</a>) at 10 µg
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 37 kDa
Observed band size: 118 kDa,18 kDa,36 kDa
true
Exposure time: 1min
- WB
CiteAb
Western blot - Anti-Adenosine A1 Receptor antibody (AB82477)
Adenosine A1 Receptor western blot using anti-Adenosine A1 Receptor antibody ab82477. Publication image and figure legend from Zhai, W., Chen, D., et al., 2016, Mol Brain, PubMed 27301321.
ab82477 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab82477 please see the product overview.
Changes in adenosine receptor expression in vivo and in vitro. a Western blot analysis of adenosine receptor expression at different time points following ICH in vivo. A1AR levels peaked at 48 h. b Quantification of the results in panel A. Bars represent relative protein levels. The mean values of the protein levels in the sham group were normalized to 1.0. *p < 0.05 for the 48 h ICH group versus the sham group. c Western blots of adenosine receptor expression in vitro. A1AR levels peaked at 48 h. d Quantification of the results in panel C. Bars represents relative protein levels. The mean values of the protein levels in the control group were normalized to 1.0. *p < 0.05 for the 48 h OxyHb group versus the control group. e and f Immunofluorescence in vivo. Double immunofluorescence analysis was performed with A1AR antibodies (green) and neuronal or astrocyte marker (NeuN/GFAP, red), and nuclei were fluorescently labeled with DAPI (blue). Scale bar = 32 μm. G : Immunofluorescence in vitro. Double immunofluorescence analysis was performed with A1AR antibodies (green) and neuronal marker (NeuN, red), and nuclei were fluorescently labeled with DAPI (blue). Scale bar = 20 μm
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The A1 receptor plays a significant role in mediating the inhibitory effects of adenosine on neurotransmitter release. It regulates synaptic transmission modulates excitability and protects tissues from excessive stimulation. This receptor does not function alone but is part of complex networks interacting with other proteins such as A2A receptors. A1 adenosine receptor signaling contributes to cardioprotection neuroprotection and regulation of renal blood flow reflecting its importance in maintaining homeostasis.
Pathways
The A1 receptor is essential in the adenosine signaling pathway and myocardial protection pathway. Through these pathways it influences important physiological responses like heart rate and blood flow. It interacts with proteins such as adenosine kinase and adenosine deaminase which regulate adenosine concentration influencing the availability of adenosine for receptor binding. The pathways involved illustrate the receptor's role in balancing energy supply and demand.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (37)
Recent publications for all applications. Explore the full list and refine your search
Molecules (Basel, Switzerland) 30: PubMed40733187
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cureus 16:e75926 PubMed39830563
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutical biology 62:456-471 PubMed38773737
2024
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 30:e14726 PubMed38715251
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 5:101477 PubMed38508143
2024
Applications
Unspecified application
Species
Unspecified reactive species
Animal nutrition (Zhongguo xu mu shou yi xue hui) 13:282-288 PubMed37168450
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 10: PubMed36359350
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neural regeneration research 17:2504-2511 PubMed35535903
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 15:783478 PubMed35002628
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 8:761164 PubMed34805317
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com